Natco has proven technical and operational expertise of over two decades in developing and commercialising niche APIs. Our unwavering commitment to quality; cGMP compliance to deliver affordable drug substances with novelty, and improving market access for patients across the world is at the core of everything we do.
Over the years, Natco has emerged as high quality and reliable, niche API manufacturer with an experience of manufacturing more than 50 APIs. While Oncology continues to be our key therapeutic domain, our API product portfolio is getting broad-based to include Central Nervous System (CNS), pain management and CV care. Natco leverages its strength of intellectual property, operational expertise and regulatory support in creating first-to-market opportunities for our customers.
Our two world class API manufacturing facilities have over 50% of their premises under Green Belt as a part of our commitment to Environment, Health and Safety which is one of our core corporate values. Natco has successful track record of regulatory inspections by USFDA, TGA, Hamburg Health Agency, PMDA, KFDA, Cofepris/Mexico and EDQM. Click here for detailed facility Inspection history and ISO certifications.
To know more about our product portfolio and/or enquiries concerning APIs, please write to api@natcopharma.co.in
| Product | Therapeutic Category |
|---|---|
| Salmeterol Xinafoate | Anti-asthmatic |
| Citalopram Hydrobromide | Anti-depressant |
| Escitalopram Oxalate | Anti-depressant |
| Sertraline Form I | Anti-depressant |
| Rizatriptan Benzoate (RTB) | Anti-migraine |
| Zolmitriptan | Anti-migraine |
| Sumatriptan Succinate | Anti-migraine |
| Ibandronate Sodium Monohydrate | Anti-osteoporosis |
| Omeprazole | G I Disorders |
| Lansoprazole | G I Disorders |
| Pantoprazole Sodium Sesquihydrate | G I Disorders |
| Anastrozole | Oncology |
| Granisetron Hydrochloride | Oncology |
| Imatinib Mesylate (Alpha 2-Form) | Oncology |
| Ondansetron Hydrochloride | Oncology |
| Ondansetron Hydrochloride (Injectable Grade) | Oncology |
| Zoledronic Acid | Oncology |
| Erlotinib Hydrochloride | Oncology |
| Letrozole (LTZ) | Oncology |
| Sorafenib Tosylate | Oncology |
| Everolimus | Oncology |
| Bendamustine HCL | Oncology |
| Bosentan | Pulmonary Hypertension |
| Ambrisentan | Pulmonary Hypertension |
| Product | Therapeutic Category |
|---|---|
| Citalopram Hydrobromide | Anti-depressant |
| Sertraline Form I | Anti-depressant |
| Escitalopram Oxalate | Anti-depressant |
| Rizatriptan Benzoate (RTB) | Anti-migraine |
| Zolmitriptan | Anti-migraine |
| Sumatriptan Succinate | Anti-migraine |
| Ibandronate Sodium Monohydrate | Anti-osteoporosis |
| Ibandronate Sodium Monohydrate (Injectable Grade) | Anti-osteoporosis |
| Omeprazole | G I Disorders |
| Pantoprazole Sodium Sesquihydrate | G I Disorders |
| Lansoprazole | G I Disorders |
| Ondansetron Hydrochloride | Oncology |
| Letrozole | Oncology |
| Anastrozole | Oncology |
| Granisetron Hydrochloride | Oncology |
| Imatinib Mesylate (Alpha 2-Form) | Oncology |
| Ondansetron Hydrochloride (Injectable Grade) | Oncology |
| Zoledronic Acid | Oncology |
| Erlotinib Hydrochloride | Oncology |
| Sorafenib Tosylate | Oncology |
| Everolimus | Oncology |
| Bendamustine HCL | Oncology |
| Salmeterol Xinafoate | Oncology |
| Bosentan | Pulmonary Hypertension |
| Ambrisentan | Pulmonary Hypertension |
For queries please email: api@natcopharma.co.in